BioSpace News Archive

electroCore, Inc. today announced that Dan Goldberger, CEO will present a company overview and be available for 1x1 meetings at the following upcoming conference: Ladenburg Thalmann 2021 Virtual Healthcare Conference Presentation Date: July 14, 2021 Presentation Time: 3:30 pm Webcast

F-star Therapeutics, Inc. today announced that the company will participate in two virtual investor conference events next week. Details are as follows: Ladenburg Thalmann Healthcare Conference 2021

AIM ImmunoTech Inc. (NYSE American: AIM) today announced that it has signed a contract to sponsor a Phase 2a Human Challenge Trial (HCT) to test the company’s drug Ampligen as a potential intranasal antiviral therapy using a human Rhinovirus hRV (common cold virus) and Influenza.

Sigilon Therapeutics, Inc. today reported that the U.S. Food and Drug Administration (FDA) has notified the Company that its Phase 1/2 study of SIG-001 in patients with severe or moderately severe hemophilia A, has been placed on clinical hold.

MediWound Ltd. today announced that a peer-reviewed publication, detailing the results of a phase 2 randomized control trial of its wound debriding product candidate EscharEx®, has been published in the Wound Repair and Regeneration Journal. An interim assessment of EscharEx’s U.S. phase 2 adaptive design study for the treatment of venous leg ulcers (VLUs) is expected by end of July 2021.

ARCA biopharma, Inc. today announced that Thomas Keuer , Chief Operating Officer, will present at the Access to Giving Virtual Investor Conference, which is being held virtually July 13-15, 2021.

Eli Lilly and Company announced new Phase 2 data showing that gene expression changes induced by mirikizumab in patients with ulcerative colitis over a 12-week induction treatment were maintained for up to one year.

SAB Biotherapeutics announced that Eddie J. Sullivan, PhD, co-founder, president and CEO, will present at the Ladenburg Thalmann Annual Healthcare Conference on Tuesday, July 13 at 5:00 p.m. ET.

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in a fireside chat during the Ladenburg Thalmann 2021 Healthcare Conference being held virtually. The fireside chat is scheduled to take place on Wednesday, July 14, 2021 at 12:30 PM ET.

According to the report, the global surgical drapes market was valued at US$ 3.1 Bn in 2019. It is projected to expand at a CAGR of 4% from 2020 to 2030.